AAAAAA
Results:
1-15
|
Results: 15
Authors:
Chrystyn, H
Citation: H. Chrystyn, Lung distribution of inhaled drugs - Reply, BR J CL PH, 52(6), 2001, pp. 717-719
Authors:
Chrystyn, H
Citation: H. Chrystyn, Methods to identify drug deposition in the lungs following inhalation, BR J CL PH, 51(4), 2001, pp. 289-299
Authors:
Hawksworth, GM
James, L
Chrystyn, H
Citation: Gm. Hawksworth et al., Characterization of the inspiratory manoeuvre when asthmatics inhale through a Turbohaler pre- and post-counselling in a community pharmacy, RESP MED, 94(5), 2000, pp. 501-504
Authors:
Chrystyn, H
Citation: H. Chrystyn, Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?, RESP MED, 94(2), 2000, pp. 177-179
Authors:
Chege, JK
Chrystyn, H
Citation: Jk. Chege et H. Chrystyn, The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation, RESP MED, 94(1), 2000, pp. 51-56
Authors:
Silkstone, VL
Tomlinson, HS
Corlett, SA
Chrystyn, H
Citation: Vl. Silkstone et al., Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged, BR J CL PH, 50(3), 2000, pp. 281-284
Authors:
Chrystyn, H
Citation: H. Chrystyn, Methods to determine lung distribution of inhaled drugs - could gamma scintigraphy be the gold standard?, BR J CL PH, 49(6), 2000, pp. 525-528
Authors:
Ashmore, SD
Jones, CH
Newstead, CG
Daly, MJ
Chrystyn, H
Citation: Sd. Ashmore et al., Ondansetron therapy for uremic pruritus in hemodialysis patients, AM J KIDNEY, 35(5), 2000, pp. 827-831
Authors:
Chrystyn, H
Citation: H. Chrystyn, The Diskus (R) inhaler - A review of its pharmaceutical and clinical performance (vol 18, pg 287, 1999), CLIN DRUG I, 18(5), 1999, pp. 403-412
Authors:
Chrystyn, H
Citation: H. Chrystyn, The Diskus (R) inhaler - A review of its pharmaceutical and clinical performance, CLIN DRUG I, 18(4), 1999, pp. 287-296
Authors:
Labiris, NRC
Holbrook, AM
Chrystyn, H
Macleod, SM
Newhouse, MT
Citation: Nrc. Labiris et al., Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis - A pilot study, AM J R CRIT, 160(5), 1999, pp. 1711-1716
Authors:
Aswania, OA
Corlett, SA
Chrystyn, H
Citation: Oa. Aswania et al., Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion, BR J CL PH, 47(6), 1999, pp. 613-618
Authors:
Hawksworth, GM
Corlett, AJ
Wright, DJ
Chrystyn, H
Citation: Gm. Hawksworth et al., Clinical pharmacy interventions by community pharmacists during the dispensing process, BR J CL PH, 47(6), 1999, pp. 695-700
Authors:
Chrystyn, H
Citation: H. Chrystyn, Anatomy and physiology in delivery: can we define our targets?, ALLERGY, 54, 1999, pp. 82-87
Authors:
El-Araud, KA
Clark, BJ
Kaahwa, C
Anum, P
Chrystyn, H
Citation: Ka. El-araud et al., The effect of dose on the characterization of aerodynamic particle-size distributions of beclomethasone dipropionate metered-dose inhalers, J PHARM PHA, 50(10), 1998, pp. 1081-1085
Risultati:
1-15
|